4 latest FDA approvals

Here are the four latest drugs and medical devices approved by the Food and Drug Administration this week.

Advertisement

1. TLE400 is an antiretroviral drug intended as a first-line treatment for HIV/AIDS patients in developing countries.

2. Xadago is an add-on treatment for patients with Parkinson’s disease who already take a combination therapy of levodopa and carbidopa for the condition, yet still experience “off” episodes.

3. Juvederm Vollure XC is a dermal filler used for the correction of moderate to severe facial wrinkles and folds.

4. The CoreValve Evolut Pro is a heart valve used for the treatment of severe aortic stenosis for patients with a high or extreme risk for open heart surgery.

More articles on supply chain:

Trump meets with Congressional Black Caucus, promises lower drug costs
Study: Surgeon scorecards reduce supply cost without affecting outcomes
FDA grants tentative approval to Mylan’s HIV/AIDS drug: 3 things to know

 

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Supply Chain

  • Abbott has launched an updated version of its Oncodetect blood test, which helps clinicians determine whether cancer remains in patients…

  • Becker’s asked supply chain leaders: If you had an extra $1 million for your supply chain budget, where would it…

  • As hospitals redefine the role of supply chain leaders to focus on enterprise strategy, digital transformation and resilience, health systems…

Advertisement

Comments are closed.